FK506 alters sarcoplasmic reticulum calcium release in neonatal piglet cardiac myocytes

1Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

Abstract

Tacrolimus (FK506) is a potent immunosuppressive drug that, when complexed to a family of immunophilin proteins known as FK binding proteins, inhibits calcineurin in T lymphocytes. Although i.v. use of FK506 in pediatric transplant recipients has been linked to development of cardiomyopathies, its mechanism of cardiotoxicity has not been examined in a neonatal animal model. In our study the effects of FK506 were investigated in cardiac myocytes isolated from newborn piglets. The peak amplitude of electrically triggered fura-2 Ca2+ transients was increased in FK506- treated myocytes, but Ca2+ transient duration and baseline fura-2 Ca2+ ratios were not altered, 45Ca2+ uptake by digitonin-lysed piglet cells decreased at pCa ≤ 6.0, indicating that sarcoplasmic reticulum efflux channels were leaky. The results suggest that elevated release of sarcoplasmic reticulum Ca2+ during systole contributes to cardiotoxic effects observed in children.

Cite

CITATION STYLE

APA

Hohl, C. M., & Altschuld, R. A. (1999). FK506 alters sarcoplasmic reticulum calcium release in neonatal piglet cardiac myocytes. Pediatric Research, 46(3), 316–319. https://doi.org/10.1203/00006450-199909000-00011

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free